Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CANAGLIFLOZIN vs NILOTINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CANAGLIFLOZIN vs NILOTINIB: Safety Overview

Metric CANAGLIFLOZIN NILOTINIB
Total FAERS Reports 24,411 23,171
Deaths Reported 544 4,543
Death Rate 2.2% 19.6%
Hospitalizations 9,503 4,846
Average Patient Age 57.8 yrs 56.5 yrs
% Female Patients 49.1% 47.7%
FDA Approval Date Mar 29, 2013 Dec 15, 2025
Manufacturer Cardinal Health 107, LLC Novadoz Pharmaceuticals LLC
Route ORAL ORAL
Marketing Status Prescription Prescription